Differences
This shows you the differences between two versions of the page.
| Both sides previous revision Previous revision Next revision | Previous revision | ||
| plaquenil [2016/06/23 03:06] – Scott Larson | plaquenil [2025/06/14 03:55] (current) – [Recommended Screening Procedures] Scott Larson | ||
|---|---|---|---|
| Line 31: | Line 31: | ||
| * localized thinning of parafoveal region especially the outer-segments and RPE structural lines | * localized thinning of parafoveal region especially the outer-segments and RPE structural lines | ||
| * loss of the inner-/ | * loss of the inner-/ | ||
| + | * {{: | ||
| * mfERG | * mfERG | ||
| * Especially in suspicious or unreliable visual field loss | * Especially in suspicious or unreliable visual field loss | ||
| Line 36: | Line 37: | ||
| * Fundus Autofluorescence | * Fundus Autofluorescence | ||
| * Increased autofluorescence possibly from accumulation of outersegment debris | * Increased autofluorescence possibly from accumulation of outersegment debris | ||
| + | * {{:: | ||
| ===== Tests NOT recommended for screening ===== | ===== Tests NOT recommended for screening ===== | ||